Published in Cell Stem Cell on April 08, 2011
The promise of induced pluripotent stem cells in research and therapy. Nature (2012) 5.05
Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81
Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell (2012) 3.80
MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res (2012) 3.53
Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer (2012) 2.79
miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol (2011) 2.79
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 2.52
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
MicroRNAs and developmental timing. Curr Opin Genet Dev (2011) 2.05
Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods (2012) 1.91
Induced neuronal cells: how to make and define a neuron. Cell Stem Cell (2011) 1.77
Molecular roadblocks for cellular reprogramming. Mol Cell (2012) 1.74
The role of miRNAs in regulating gene expression networks. J Mol Biol (2013) 1.74
Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73
p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol (2012) 1.63
Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol (2012) 1.56
Biophysical regulation of epigenetic state and cell reprogramming. Nat Mater (2013) 1.55
Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev (2011) 1.55
MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity. Cell Stem Cell (2010) 1.53
HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development (2011) 1.50
The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol (2011) 1.44
Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep (2012) 1.42
MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells (2013) 1.41
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic. Cancer Res (2013) 1.41
Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol (2014) 1.38
Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem cell proliferation. Nat Commun (2012) 1.35
Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev (2013) 1.34
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression. Nat Protoc (2012) 1.32
Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31
RNA viruses and the host microRNA machinery. Nat Rev Microbiol (2013) 1.31
Breathing-in epigenetic change with vitamin C. EMBO Rep (2013) 1.29
HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS One (2012) 1.25
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Transl Med (2012) 1.24
The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol (2012) 1.23
The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS One (2013) 1.22
Molecular control of induced pluripotency. Cell Stem Cell (2014) 1.22
A review of the methods for human iPSC derivation. Methods Mol Biol (2013) 1.22
Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther (2012) 1.19
Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells (2013) 1.19
The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA (2012) 1.18
Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res (2012) 1.18
Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells (2012) 1.18
MicroRNAs are shaping the hematopoietic landscape. Haematologica (2011) 1.17
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep (2013) 1.17
Induced regeneration--the progress and promise of direct reprogramming for heart repair. Nat Med (2013) 1.17
Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep (2014) 1.16
From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev (2011) 1.15
The transcriptional regulation of pluripotency. Cell Res (2012) 1.15
Epigenetic factors influencing resistance to nuclear reprogramming. Trends Genet (2011) 1.14
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther (2013) 1.14
A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation. Nat Commun (2012) 1.14
Naive and primed murine pluripotent stem cells have distinct miRNA expression profiles. RNA (2011) 1.13
Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Res Ther (2011) 1.12
Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci (2012) 1.12
microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. Cell Res (2012) 1.12
Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res (2012) 1.12
miR-99a/100~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling. Genes Dev (2014) 1.11
Crosstalk among Epigenetic Pathways Regulates Neurogenesis. Front Neurosci (2012) 1.10
The abbreviated pluripotent cell cycle. J Cell Physiol (2013) 1.09
Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Pharmacol (2012) 1.09
Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming. Hum Mol Genet (2012) 1.07
Assessing iPSC reprogramming methods for their suitability in translational medicine. J Cell Biochem (2012) 1.07
Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8. EMBO Rep (2012) 1.07
Pluripotent stem cell energy metabolism: an update. EMBO J (2014) 1.05
Regulation of stem cell populations by microRNAs. Adv Exp Med Biol (2013) 1.04
Two miRNA clusters reveal alternative paths in late-stage reprogramming. Cell Stem Cell (2014) 1.04
Cardiac regeneration: current therapies-future concepts. J Thorac Dis (2013) 1.04
Inducing iPSCs to escape the dish. Cell Stem Cell (2011) 1.03
Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther (2014) 1.03
microRNA control of mouse and human pluripotent stem cell behavior. Annu Rev Cell Dev Biol (2013) 1.02
Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res (2011) 1.02
miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J Clin Invest (2014) 1.02
Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med (2012) 1.02
The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation. Genome Biol (2012) 1.00
Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med (2013) 1.00
Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases. Curr Gene Ther (2013) 1.00
Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta (2012) 1.00
miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep (2011) 0.99
Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid Med Cell Longev (2013) 0.99
MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS One (2012) 0.99
MicroRNA-29a promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction. J Am Soc Nephrol (2014) 0.99
miR-294/miR-302 promotes proliferation, suppresses G1-S restriction point, and inhibits ESC differentiation through separable mechanisms. Cell Rep (2013) 0.99
Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol (2013) 0.98
Global analysis reveals multiple pathways for unique regulation of mRNA decay in induced pluripotent stem cells. Genome Res (2012) 0.98
Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res (2012) 0.98
Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med (2012) 0.98
X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry (2012) 0.97
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement (2012) 0.96
Small but sturdy: small RNAs in cellular memory and epigenetics. Genes Dev (2014) 0.96
Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol (2013) 0.96
CD90- (Thy-1-) high selection enhances reprogramming capacity of murine adipose-derived mesenchymal stem cells. Dis Markers (2013) 0.96
MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat Struct Mol Biol (2013) 0.95
MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS One (2013) 0.95
MicroRNAs as novel regulators of stem cell fate. World J Stem Cells (2013) 0.94
Bright/Arid3A acts as a barrier to somatic cell reprogramming through direct regulation of Oct4, Sox2, and Nanog. Stem Cell Reports (2014) 0.93
Regulatory non-coding RNAs in pluripotent stem cells. Int J Mol Sci (2013) 0.93
Generation of induced pluripotent stem cells from human renal proximal tubular cells with only two transcription factors, OCT4 and SOX2. J Biol Chem (2012) 0.93
Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med (2013) 0.93
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26
An extended transcriptional network for pluripotency of embryonic stem cells. Cell (2008) 14.64
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev (1991) 13.28
Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol (2008) 10.97
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol (2008) 10.29
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet (2007) 9.25
Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med (2010) 9.19
Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev (2008) 7.07
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (2010) 6.40
Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature (2010) 6.20
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet (2008) 5.26
Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol (2009) 5.14
Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature (2010) 5.10
Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell (2007) 4.94
Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell (2009) 4.38
Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol (2008) 4.07
Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell (2010) 4.03
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells (2010) 3.53
The miR-430/427/302 family controls mesendodermal fate specification via species-specific target selection. Dev Cell (2009) 3.01
Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development (2002) 2.88
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J (2003) 2.81
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle (2010) 2.64
Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest (2009) 1.83
Cell cycle regulation by MicroRNAs in embryonic stem cells. Cancer Res (2009) 1.69
Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy. J Biol Chem (2008) 1.48
Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J (2009) 1.43
A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc (2010) 1.17
PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 13.08
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell (2006) 10.18
Transcriptional control of brown fat determination by PRDM16. Cell Metab (2007) 6.79
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A (2004) 6.53
PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature (2010) 5.26
Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab (2006) 5.01
The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. Nat Neurosci (2006) 4.49
Interconversion between intestinal stem cell populations in distinct niches. Science (2011) 4.23
Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell (2005) 4.04
Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg (2002) 3.62
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med (2007) 3.61
Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development (2007) 3.56
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med (2004) 3.55
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature (2005) 3.44
beta-Catenin is required for specification of proximal/distal cell fate during lung morphogenesis. J Biol Chem (2003) 3.37
A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet (2008) 3.37
PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell (2004) 3.24
The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab (2007) 3.05
Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol (2003) 3.01
Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation (2002) 2.93
Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development (2002) 2.88
FoxP2 expression in avian vocal learners and non-learners. J Neurosci (2004) 2.87
Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J Clin Invest (2003) 2.76
Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Dev Biol (2005) 2.73
Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut. Dev Cell (2009) 2.72
Nf1 has an essential role in endothelial cells. Nat Genet (2002) 2.63
Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell (2004) 2.62
Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood (2010) 2.57
Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A (2008) 2.55
Hop is an unusual homeobox gene that modulates cardiac development. Cell (2002) 2.52
Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev Biol (2005) 2.49
Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol (2004) 2.48
Getting your Pax straight: Pax proteins in development and disease. Trends Genet (2002) 2.48
Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development (2008) 2.46
Coordinated actions of the forkhead protein Foxp1 and Hox proteins in the columnar organization of spinal motor neurons. Neuron (2008) 2.44
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation (2005) 2.44
Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development (2007) 2.44
Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med (2002) 2.39
Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature (2005) 2.37
The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet (2008) 2.32
Biomarker system for studying muscle, stem cells, and cancer in vivo. FASEB J (2009) 2.31
Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development (2004) 2.27
Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. Dev Biol (2007) 2.26
Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1. Dev Cell (2011) 2.23
Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell (2009) 2.17
Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest (2007) 2.12
An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest (2007) 2.09
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol (2010) 2.07
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev Cell (2012) 2.06
Somitic origin of limb muscle satellite and side population cells. Proc Natl Acad Sci U S A (2006) 2.01
Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation (2006) 2.00
GATA6 is essential for embryonic development of the liver but dispensable for early heart formation. Mol Cell Biol (2005) 2.00
High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice. Genesis (2005) 1.99
Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells. Development (2004) 1.99
Flexible high-performance carbon nanotube integrated circuits. Nat Nanotechnol (2011) 1.97
Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet (2004) 1.95
Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery. J Clin Invest (2004) 1.95
A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95
Hyponatremia-induced osteoporosis. J Bone Miner Res (2010) 1.95
Rapid 3D phenotyping of cardiovascular development in mouse embryos by micro-CT with iodine staining. Circ Cardiovasc Imaging (2010) 1.94
Homeobox protein Hop functions in the adult cardiac conduction system. Circ Res (2005) 1.93
Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol (2008) 1.90
Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS One (2009) 1.87
Foxp-mediated suppression of N-cadherin regulates neuroepithelial character and progenitor maintenance in the CNS. Neuron (2012) 1.86
Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. Genes Dev (2006) 1.85
Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest (2009) 1.83
GATA6 regulates differentiation of distal lung epithelium. Development (2002) 1.82
Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg (2012) 1.79
Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol (2005) 1.79
RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells. Proc Natl Acad Sci U S A (2007) 1.78
Cardiac neural crest. Semin Cell Dev Biol (2005) 1.77
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci U S A (2006) 1.77
Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci U S A (2004) 1.77
Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest (2008) 1.76
Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med (2007) 1.76
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Proc Natl Acad Sci U S A (2011) 1.76
Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J (2008) 1.76
Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell (2010) 1.75
Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci U S A (2005) 1.70
Fog2 is required for normal diaphragm and lung development in mice and humans. PLoS Genet (2005) 1.69
Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev Biol (2005) 1.69
The three R's of lung health and disease: repair, remodeling, and regeneration. J Clin Invest (2011) 1.68
Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. J Clin Invest (2011) 1.67
Myocardial Notch signaling reprograms cardiomyocytes to a conduction-like phenotype. Circulation (2012) 1.66
Lung development: orchestrating the generation and regeneration of a complex organ. Development (2014) 1.66
A technique for retrograde intubation in mice. Lab Anim (NY) (2006) 1.65
Retrotransposons and their recognition of pol II promoters: a comprehensive survey of the transposable elements from the complete genome sequence of Schizosaccharomyces pombe. Genome Res (2003) 1.63
Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg (2005) 1.63
Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J Clin Invest (2008) 1.63